Global Vaccines Market Analysis 2019

The Global Vaccines market is expected to reach $71.04 billion by 2026 growing at a CAGR of 8.7% from 2018 to 2026. Vaccine is a biological preparation that is administered to produce acquired immunity in patients. Organization of vaccines helps to enhance the immune response against a particular pathogen. They play an essential role to maintain sustainable health of individuals across various nations; hence, they are utilized in different regional disease-prevention methodologies. They are essentially administered to individuals of various age groups, which strengthen their immune system throughout lifetime and offers security against various types of infectious diseases. Factors such as rise in prevalence of diseases, increasing government initiatives towards immunization and increasing number of prospects from the developing economies are driving the market growth. Though, high cost of development and complexities related to manufacturing are projected to inhibit the growth of the market. Moreover, high growth prospects in emerging markets may provide ample opportunities for the market growth. By technology, recombinant vaccines segment acquired significant growth in the market owing to less side-effect of these vaccines in comparison to conventional ones. They are largely used in animals for prevention of diseases such as pneumonia, foot and mouth disease, septicaemia and pox disease that will further support the business growth. Developments in the field of molecular biology and genetic engineering will positively impact the growth of market. The key vendors mentioned are Emergent Biosolutions, Glaxosmithkline, Pfizer, Sanofi Pasteur, Merck, Medimmune, LLC (A Subsidiary of Astrazeneca), CSL Limited, Serum Institute of India, Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Astellas Pharma, Panacea Biotec, Bavarian Nordic, Biological E and Daiichi Sankyo Company. Patient Types Covered: • Pediatric Patients • Adult Patients Types Covered: • Monovalent Vaccines • Multivalent Vaccines Route of Administrations Covered: • Oral Administration • Intramuscular and Subcutaneous Administration • Injectable • Other Routes of Administration Indications Covered: • Foot and Mouth Disease • Respiratory Syncytial Virus (RSV) • Cancer • Cholera • Human Papilloma Virus (HPV) • Influenza • Diphtheria, Pertussis, and Tetanus (DPT) • Meningococcal Disease • Hepatitis • Varicella • Herpes Zoster • Measles, Mumps, and Rubella (MMR) • Dengue • Rotavirus • Pneumococcal Disease • Polio • Disease Technologies Covered: • Attenuated Vaccines • Recombinant Vaccines • Inactivated & Subunit Vaccines • Toxoid Vaccines • Live Attenuated Vaccines • Conjugate Vaccines Distribution Channel Covered: • Retail Pharmacies • Institutional Sale • Hospital Pharmacies End Users Covered: • Pediatric Vaccines • Traveler Vaccines • Adult Vaccines Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period

1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Vaccines Market, By Patient Type
5.1 Introduction
5.2 Pediatric Patients
5.3 Adult Patients

6 Global Vaccines Market, By Type
6.1 Introduction
6.2 Monovalent Vaccines
6.3 Multivalent Vaccines

7 Global Vaccines Market, By Route of Administration
7.1 Introduction
7.2 Oral Administration
7.3 Intramuscular and Subcutaneous Administration
7.4 Injectable
7.5 Other Routes of Administration

8 Global Vaccines Market, By Indication
8.1 Introduction
8.2 Foot and Mouth Disease
8.3 Respiratory Syncytial Virus (RSV)
8.4 Cancer
8.5 Cholera
8.6 Human Papilloma Virus (HPV)
8.7 Influenza
8.8 Diphtheria, Pertussis, and Tetanus (DPT)
8.9 Meningococcal Disease
8.10 Hepatitis
8.11 Varicella
8.12 Herpes Zoster
8.13 Measles, Mumps, and Rubella (MMR)
8.14 Dengue
8.15 Rotavirus
8.16 Pneumococcal Disease
8.17 Polio
8.18 Disease

9 Global Vaccines Market, By Technology
9.1 Introduction
9.2 Attenuated Vaccines
9.3 Recombinant Vaccines
9.4 Inactivated & Subunit Vaccines
9.5 Toxoid Vaccines
9.6 Live Attenuated Vaccines
9.7 Conjugate Vaccines

10 Global Vaccines Market, By Distribution Channel
10.1 Introduction
10.2 Retail Pharmacies
10.3 Institutional Sale
10.4 Hospital Pharmacies

11 Global Vaccines Market, By End User
11.1 Introduction
11.2 Pediatric Vaccines
11.3 Traveler Vaccines
11.4 Adult Vaccines

10 Global Vaccines Market, By Geography
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia Pacific
10.5 South America
10.6 Middle East & Africa

11 Strategic Benchmarking

12 Vendors Landscape
12.1 Emergent Biosolutions
12.2 Glaxosmithkline
12.3 Pfizer
12.4 Sanofi Pasteur
12.5 Merck
12.6 Medimmune, LLC (A Subsidiary of Astrazeneca)
12.7 CSL Limited
12.8 Serum Institute of India
12.9 Johnson & Johnson
12.10 Mitsubishi Tanabe Pharma Corporation
12.11 Astellas Pharma
12.12 Panacea Biotec
12.13 Bavarian Nordic
12.14 Biological E
12.15 Daiichi Sankyo Company

List of Data Tables
Table 1 Global Vaccines Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Vaccines Market Outlook, By Patient Type (2016-2026) ($MN)
Table 3 Global Vaccines Market Outlook, By Pediatric Patients (2016-2026) ($MN)
Table 4 Global Vaccines Market Outlook, By Adult Patients (2016-2026) ($MN)
Table 5 Global Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 6 Global Vaccines Market Outlook, By Monovalent Vaccines (2016-2026) ($MN)
Table 7 Global Vaccines Market Outlook, By Multivalent Vaccines (2016-2026) ($MN)
Table 8 Global Vaccines Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 9 Global Vaccines Market Outlook, By Oral Administration (2016-2026) ($MN)
Table 10 Global Vaccines Market Outlook, By Intramuscular and Subcutaneous Administration (2016-2026) ($MN)
Table 11 Global Vaccines Market Outlook, By Injectable (2016-2026) ($MN)
Table 12 Global Vaccines Market Outlook, By Other Routes of Administration (2016-2026) ($MN)
Table 13 Global Vaccines Market Outlook, By Indication (2016-2026) ($MN)
Table 14 Global Vaccines Market Outlook, By Foot and Mouth Disease (2016-2026) ($MN)
Table 15 Global Vaccines Market Outlook, By Respiratory Syncytial Virus (RSV) (2016-2026) ($MN)
Table 16 Global Vaccines Market Outlook, By Cancer (2016-2026) ($MN)
Table 17 Global Vaccines Market Outlook, By Cholera (2016-2026) ($MN)
Table 18 Global Vaccines Market Outlook, By Human Papilloma Virus (HPV) (2016-2026) ($MN)
Table 19 Global Vaccines Market Outlook, By Influenza (2016-2026) ($MN)
Table 20 Global Vaccines Market Outlook, By Diphtheria, Pertussis, and Tetanus (DPT) (2016-2026) ($MN)
Table 21 Global Vaccines Market Outlook, By Meningococcal Disease (2016-2026) ($MN)
Table 22 Global Vaccines Market Outlook, By Hepatitis (2016-2026) ($MN)
Table 23 Global Vaccines Market Outlook, By Varicella (2016-2026) ($MN)
Table 24 Global Vaccines Market Outlook, By Herpes Zoster (2016-2026) ($MN)
Table 25 Global Vaccines Market Outlook, By Measles, Mumps, and Rubella (MMR) (2016-2026) ($MN)
Table 26 Global Vaccines Market Outlook, By Dengue (2016-2026) ($MN)
Table 27 Global Vaccines Market Outlook, By Rotavirus (2016-2026) ($MN)
Table 28 Global Vaccines Market Outlook, By Pneumococcal Disease (2016-2026) ($MN)
Table 29 Global Vaccines Market Outlook, By Polio (2016-2026) ($MN)
Table 30 Global Vaccines Market Outlook, By Disease (2016-2026) ($MN)
Table 31 Global Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 32 Global Vaccines Market Outlook, By Attenuated Vaccines (2016-2026) ($MN)
Table 33 Global Vaccines Market Outlook, By Recombinant Vaccines (2016-2026) ($MN)
Table 34 Global Vaccines Market Outlook, By Inactivated & Subunit Vaccines (2016-2026) ($MN)
Table 35 Global Vaccines Market Outlook, By Toxoid Vaccines (2016-2026) ($MN)
Table 36 Global Vaccines Market Outlook, By Live Attenuated Vaccines (2016-2026) ($MN)
Table 37 Global Vaccines Market Outlook, By Conjugate Vaccines (2016-2026) ($MN)
Table 38 Global Vaccines Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 39 Global Vaccines Market Outlook, By Retail Pharmacies (2016-2026) ($MN)
Table 40 Global Vaccines Market Outlook, By Institutional Sale (2016-2026) ($MN)
Table 41 Global Vaccines Market Outlook, By Hospital Pharmacies (2016-2026) ($MN)
Table 42 Global Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 43 Global Vaccines Market Outlook, By Pediatric Vaccines (2016-2026) ($MN)
Table 44 Global Vaccines Market Outlook, By Traveler Vaccines (2016-2026) ($MN)
Table 45 Global Vaccines Market Outlook, By Adult Vaccines (2016-2026) ($MN)
Table 46 North America Vaccines Market Outlook, By Patient Type (2016-2026) ($MN)
Table 47 North America Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 48 North America Vaccines Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 49 North America Vaccines Market Outlook, By Indication (2016-2026) ($MN)
Table 50 North America Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 51 North America Vaccines Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 52 North America Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 53 Europe Vaccines Market Outlook, By Patient Type (2016-2026) ($MN)
Table 54 Europe Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 55 Europe Vaccines Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 56 Europe Vaccines Market Outlook, By Indication (2016-2026) ($MN)
Table 57 Europe Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 58 Europe Vaccines Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 59 Europe Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 60 Asia Pacific Vaccines Market Outlook, By Patient Type (2016-2026) ($MN)
Table 61 Asia Pacific Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 62 Asia Pacific Vaccines Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 63 Asia Pacific Vaccines Market Outlook, By Indication (2016-2026) ($MN)
Table 64 Asia Pacific Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 65 Asia Pacific Vaccines Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 66 Asia Pacific Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 67 South America Vaccines Market Outlook, By Patient Type (2016-2026) ($MN)
Table 68 South America Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 69 South America Vaccines Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 70 South America Vaccines Market Outlook, By Indication (2016-2026) ($MN)
Table 71 South America Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 72 South America Vaccines Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 73 South America Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 74 Middle east & Africa Vaccines Market Outlook, By Patient Type (2016-2026) ($MN)
Table 75 Middle east & Africa Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 76 Middle east & Africa Vaccines Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 77 Middle east & Africa Vaccines Market Outlook, By Indication (2016-2026) ($MN)
Table 78 Middle east & Africa Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 79 Middle east & Africa Vaccines Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 80 Middle east & Africa Vaccines Market Outlook, By End User (2016-2026) ($MN)